abstract |
Sustained release drug delivery devices including scaffolds comprising combinations of anti-connexin, anti-gap junction, anti-hemichannel and/or other agents, for example, anti-connexin 26 and anti-connexin 43 polynucleotides or peptidomimetics, uses therefor, and kits comprising sustained release scaffold. |